Robert W Dubois

Summary

Publications

  1. ncbi Are ACOs ready to be accountable for medication use?
    Robert W Dubois
    National Pharmaceutical Council, 1717 Pennsylvania Ave, NW, Ste 800, Washington, DC 20006, USA
    J Manag Care Pharm 20:17-21. 2014
  2. doi When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption
    Robert W Dubois
    National Pharmaceutical Council, 1717 Pennsylvania Avenue, NW, Suite 800, Washington, DC 20006, USA
    J Comp Eff Res 2:383-91. 2013
  3. doi Interview: A private sector life in comparative effectiveness research. Interview with Robert W Dubois
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    J Comp Eff Res 2:429-31. 2013
  4. ncbi Looking at CER from the pharmaceutical industry perspective
    Robert W Dubois
    NationalPharmaceutical Council, Washington, DC 20006, USA
    J Manag Care Pharm 18:S9-12. 2012
  5. doi Setting priorities for comparative effectiveness research: from assessing public health benefits to being open with the public
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    Health Aff (Millwood) 30:2235-42. 2011

Detail Information

Publications5

  1. ncbi Are ACOs ready to be accountable for medication use?
    Robert W Dubois
    National Pharmaceutical Council, 1717 Pennsylvania Ave, NW, Ste 800, Washington, DC 20006, USA
    J Manag Care Pharm 20:17-21. 2014
    ..Most ACOs have not yet focused on this integral facet of care, even though medications are a critical component to achieving the lower costs and improved quality that are anticipated with this new model...
  2. doi When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption
    Robert W Dubois
    National Pharmaceutical Council, 1717 Pennsylvania Avenue, NW, Suite 800, Washington, DC 20006, USA
    J Comp Eff Res 2:383-91. 2013
    ....
  3. doi Interview: A private sector life in comparative effectiveness research. Interview with Robert W Dubois
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    J Comp Eff Res 2:429-31. 2013
    b>Robert W Dubois joined the National Pharmaceutical Council (Washington, DC, USA) in October 2010 as its Chief Science Officer...
  4. ncbi Looking at CER from the pharmaceutical industry perspective
    Robert W Dubois
    NationalPharmaceutical Council, Washington, DC 20006, USA
    J Manag Care Pharm 18:S9-12. 2012
    ..But the growth of CER also brings an array of questions and decisions for purchasers and policy makers that will not be easy to answer and which require significant dialogue to fully understand and address...
  5. doi Setting priorities for comparative effectiveness research: from assessing public health benefits to being open with the public
    Robert W Dubois
    National Pharmaceutical Council, Washington, DC, USA
    Health Aff (Millwood) 30:2235-42. 2011
    ..We also recommend that during the priority-setting process, there should be transparent conversations among those who make decisions about the priorities and the public...